Patents

US 12552810 B2: Crystalline forms of CFTR modulators

Granted
2026-02-17
Filed
2021-08-12 application 18020802
Type
Utility · 13 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Crystalline forms of salts of Compound I are disclosed. Pharmaceutical compositions comprising the same, methods of treating cystic fibrosis using the same, and methods for making the same are also disclosed.

Source: PTBLXML, file of 2026-02-17 (ipgb20260217.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Vertex Pharmaceuticals Incorporated 764 patentsUS company or organizationBoston, MAPTBLXML, file of 2026-02-17

Inventors

InventorPlacePatentsPerson pageSource
Satish Kumar IyemperumalReading, GBPTBLXML, file of 2026-02-17
Andrey PeresypkinNewton, MAPTBLXML, file of 2026-02-17
Yi ShiNatick, MAPTBLXML, file of 2026-02-17
Muna ShresthaBelmont, MA11PTBLXML, file of 2026-02-17

CPC categories

SubclassCategoryFirst groupSource
C07DHeterocyclic compoundsC07D513/22PTBLXML, file of 2026-02-17
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P11/00PTBLXML, file of 2026-02-17
C07BGeneral methods of organic chemistry; apparatus thereforC07B2200/13PTBLXML, file of 2026-02-17

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

No recorded assignments or security interests on file for this patent.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.